Related Experiment Video

Updated: May 31, 2026

Use of Capillary Electrophoresis Immunoassay to Search for Potential Biomarkers of Amyotrophic Lateral Sclerosis in Human Platelets
11:03

Use of Capillary Electrophoresis Immunoassay to Search for Potential Biomarkers of Amyotrophic Lateral Sclerosis in Human Platelets

Published on: February 10, 2020

Identifying blood biomarkers to improve the diagnosis of stroke

W Whiteley1

  • 1Division of Clinical Neurosciences, University of Edinburgh,Western General Hospital, Edinburgh, UK. william.whiteley@ed.ac.uk

The Journal of the Royal College of Physicians of Edinburgh
|June 17, 2011
PubMed

Insights

Blood biomarkers show potential for diagnosing stroke and predicting recurrence. Further research is needed to validate their clinical utility in stroke patient management.

Area of Science:

  • Neurology
  • Biochemistry
  • Clinical Medicine

Background:

  • Blood biomarkers are crucial in managing various diseases.
  • Their application in stroke care, particularly for diagnosis and recurrence prediction, remains under investigation.
  • Accurate prediction could significantly improve patient outcomes.

Purpose of the Study:

  • To systematically review the literature on blood biomarkers for stroke.
  • To evaluate the diagnostic performance of existing blood biomarkers for stroke.
  • To assess the predictive value of inflammatory markers for recurrent stroke and myocardial infarction.

Main Methods:

  • Systematic literature review of blood biomarker studies in stroke.
  • Performance analysis of biomarkers for stroke diagnosis.
  • Examination of inflammatory markers for predicting stroke and myocardial infarction recurrence.

Main Results:

  • The review identified existing blood biomarkers for stroke diagnosis.
  • Performance metrics for these diagnostic biomarkers were determined.
  • The predictive value of inflammatory markers for recurrent events was examined.

Conclusions:

  • Blood biomarkers hold promise for stroke diagnosis and recurrence prediction.
  • Further validation is required to integrate these biomarkers into clinical practice for stroke management.
  • Inflammatory markers may play a role in predicting adverse vascular events post-stroke.

More Related Videos

Dried Blood Spot Collection of Health Biomarkers to Maximize Participation in Population Studies07:20

Dried Blood Spot Collection of Health Biomarkers to Maximize Participation in Population Studies

Published on: January 28, 2014

Identification of Disease-related Spatial Covariance Patterns using Neuroimaging Data14:27

Identification of Disease-related Spatial Covariance Patterns using Neuroimaging Data

Published on: June 26, 2013

Related Concept Videos

Blood Studies for Cardiovascular System I: Cardiac Biomarkers01:20

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
Stroke: Introduction and Types01:29

Stroke: Introduction and Types

A stroke is an acute neurological event caused by the sudden disruption of cerebral blood flow, leading to rapid loss of neuronal function. Neurons depend on continuous oxygen and glucose supply, so even brief interruptions can cause irreversible injury within minutes. Strokes are classified into ischemic and hemorrhagic types.Ischemic StrokeIschemic strokes are most common and occur due to arterial occlusion, depriving brain tissue of oxygen and nutrients. This leads to energy failure, ionic...
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
Hemorrhagic Stroke l: Introduction01:17

Hemorrhagic Stroke l: Introduction

A hemorrhagic stroke is an acute neurological event that occurs when a weakened cerebral blood vessel ruptures, allowing blood to accumulate within or around the brain. The sudden release of blood forms a focal hematoma that increases intracranial pressure, displaces neural tissue, and can obstruct cerebrospinal fluid pathways. These effects may be compounded by intraventricular extension of the hemorrhage, cerebral edema, or compression of adjacent structures, all of which contribute to...
Hemorrhagic Stroke ll: Pathophysiology01:29

Hemorrhagic Stroke ll: Pathophysiology

A hemorrhagic stroke develops when a cerebral blood vessel ruptures, allowing blood to escape into the surrounding brain tissue, as in intracerebral hemorrhage (ICH), or into the subarachnoid space, as in subarachnoid hemorrhage (SAH). Because the skull is a rigid compartment, the sudden presence of extravascular blood rapidly increases intracranial pressure and compresses adjacent neural structures, leading to immediate tissue injury and impaired cerebral perfusion.Mass Effect and Primary...